Literature DB >> 12862141

Isoniazid prophylaxis for tuberculosis prevention among HIV infected police officers in Dar es Salaam.

M Bakari1, A Moshi, E A Aris, S Chale, R Josiah, P Magao, N Pallangyo, F Mugusi, E Sandström, G Biberfeld, F Mhalu, K Pallangyo.   

Abstract

OBJECTIVE: To determine the acceptability, compliance and side effects of isoniazid (INH) prophylaxis against tuberculosis among HIV infected police officers (PO) in Dar es Salaam.
DESIGN: A nested study from a prospective follow up of a cohort of police officers.
SETTING: Dar es Salaam, Tanzania.
SUBJECTS: One hundred and forty three HIV-1 infected police officers. MAIN OUTCOME MEASURES: Acceptance and compliance to INH prophylaxis.
RESULTS: Of the 400 HIV-1 infected officers, 143 (35.7%) came forward for post-test counselling and HIV test results. Sixty per cent (87/143) of them accepted to be on INH prophylaxis. However only 42.5% (37/87) came forward for evaluation regarding their suitability for INH prophylaxis. During the evaluation, eight (21.6%) of 37 otherwise asymptomatic PO were found to have active pulmonary tuberculosis (TB). Eventually only 29 PO were actually started on INH, and only 16 (55.2%) of them completed the six months course. No serious side effects were observed. One PO developed TB two months after loss to follow up before completing the six months.
CONCLUSIONS: There was low acceptability of and poor compliance with INH prophylaxis among the HIV-1 infected PO despite being educated on the benefits of prophylaxis. The prevalence of PTB among asymptomatic HIV-1 infected PO was high, and therefore persons with HIV infection should be examined for TB even in the absence of symptoms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12862141     DOI: 10.4314/eamj.v77i9.46695

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  3 in total

Review 1.  Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis.

Authors:  Hendramoorthy Maheswaran; Pelham Barton
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

Review 2.  Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data.

Authors:  Titilola Makanjuola; Henock B Taddese; Andrew Booth
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

3.  Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.

Authors:  Masanja Robert; Jim Todd; Bernard J Ngowi; Sia E Msuya; Angella Ramadhani; Veryhel Sambu; Isaya Jerry; Martin R Mujuni; Michael J Mahande; James S Ngocho; Werner Maokola
Journal:  BMC Infect Dis       Date:  2020-04-10       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.